Moreover, RNF6 promotes RB cell surviving drug treatment through JAK2/STAT3 pathway, and overexpression of RNF6 in drug-sensitive RB cells could render the cells resistant to multiple chemotherapeutical drugs. The gene discussed is RNF6; the disease is retinoblastoma.